TenSixteen Bio Revenue and Competitors
Estimated Revenue & Valuation
- TenSixteen Bio's estimated annual revenue is currently $1.9M per year.
- TenSixteen Bio's estimated revenue per employee is $77,500
Employee Data
- TenSixteen Bio has 24 Employees.
- TenSixteen Bio grew their employee count by -27% last year.
TenSixteen Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Scientific co-founder | Reveal Email/Phone |
3 | VP, Head Genomics | Reveal Email/Phone |
4 | VP, Head Chemistry | Reveal Email/Phone |
5 | Associate Director, Statistical Genetics | Reveal Email/Phone |
6 | Sr. Director Clinical Development | Reveal Email/Phone |
7 | Director, Discovery Biology | Reveal Email/Phone |
8 | Principal Software Engineer | Reveal Email/Phone |
9 | Principal Data Scientist | Reveal Email/Phone |
10 | Scientist II | Reveal Email/Phone |
TenSixteen Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is TenSixteen Bio?
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases. We are a precision platform therapeutics company utilizing novel genomic biology across multiple disease areas. TenSixteen was conceived around the promise of leveraging unique data assets and capabilities to drive discovery and novel clinical development paradigms, and we are building a genomics and data science platform that will enable data integration and generation to support these efforts. We aim to transform the future of precision medicine in complex diseases.
keywords:N/AN/A
Total Funding
24
Number of Employees
$1.9M
Revenue (est)
-27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.4M | 24 | -20% | N/A |
#2 | $1.7M | 24 | -25% | $15.6M |
#3 | $4.3M | 24 | 9% | N/A |
#4 | $2M | 24 | -27% | N/A |
#5 | $2.4M | 24 | N/A | N/A |